The recent failure of the PROMESA clinical trial for multiple system atrophy raises the question—are polyphenols a viable therapeutic option against proteinopathies?
@article{ATM35635,
author = {Gal Bitan},
title = {The recent failure of the PROMESA clinical trial for multiple system atrophy raises the question—are polyphenols a viable therapeutic option against proteinopathies?},
journal = {Annals of Translational Medicine},
volume = {8},
number = {11},
year = {2020},
keywords = {},
abstract = {},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/35635}
}